Citation Impact

Citing Papers

Kidney stones and hypertension: population based study of an independent clinical association.
1990
Serenoa repens for benign prostatic hyperplasia
2012
Role of the normal gut microbiota
2015 Standout
A Critical Approach to Evaluating Clinical Efficacy, Adverse Events and Drug Interactions of Herbal Remedies
2016 Standout
Ingested Nitrate, Disinfection By-products, and Kidney Cancer Risk in Older Women
2017
Testicular Germ-Cell Cancer
1997 Standout
Kidney stones: pathophysiology and medical management
2006 Standout
Nitrate in public water supplies and the risk of renal cell carcinoma
2007
Guidelines on Urolithiasis<footref rid="foot01"><sup>1</sup></footref>
2001 Standout
Epidemiological Study of Urinary Tract Stones in a Northern Italian City
1990
Epidemiological Studies on the Prevalence of Upper Urinary Calculi in Taiwan
2002
The epidemiology of urinary tract infection
2010 Standout
Dose calculation of anticancer drugs: a review of the current practice and introduction of an alternative.
1996 Standout
Study on the Prevalence and Incidence of Urolithiasis in Germany Comparing the Years 1979 vs. 2000
2003 Standout
The Risk–Benefit Profile of Commonly Used Herbal Therapies: Ginkgo, St. John's Wort, Ginseng, Echinacea, Saw Palmetto, and Kava
2002 Standout
Sex- and age-related composition of 10 617 calculi analyzed by infrared spectroscopy
1995
Repeated Urine Analysis in Patients with Calcium Stone Disease
1998
Guidelines for Antimicrobial Treatment of Uncomplicated Acute Bacterial Cystitis and Acute Pyelonephritis in Women
1999
Hibiscus sabdariffa L. – A phytochemical and pharmacological review
2014 Standout
Prevalence and epidemiologic characteristics of urolithiasis in Seoul, Korea
2002
Phytotherapy in the treatment of benign prostatic hyperplasia: an update
1999
Prevalence of Urolithiasis in Kaizuka City, Japan—An Epidemiologic Study of Urinary Stones
1996
Diagnostic and therapeutic approaches in patients with secondary hyperoxaluria
2003
The Characterization of Feces and Urine: A Review of the Literature to Inform Advanced Treatment Technology
2015 Standout
Serenoa repens for benign prostatic hyperplasia
2002
Second Cancers Among 40 576 Testicular Cancer Patients: Focus on Long-term Survivors
2005 Standout
Oxalobacter formigenes: a potential tool for the treatment of primary hyperoxaluria type 1
2006
[13C2]oxalate absorption in children with idiopathic calcium oxalate urolithiasis or primary hyperoxaluria
2008
Hyperoxaluric calcium nephrolithiasis
2002
Thallium: a review of public health and environmental concerns
2004 Standout
Saw Palmetto Extracts for Treatment of Benign Prostatic Hyperplasia
1998
Alkali citrate prophylaxis in idiopathic recurrent calcium oxalate urolithiasis — a prospective randomized study
1994
Adult urolithiasis in a population-based study in Iran: prevalence, incidence, and associated risk factors
2007
EAU Guidelines on the Treatment and Follow-up of Non-neurogenic Male Lower Urinary Tract Symptoms Including Benign Prostatic Obstruction
2013 Standout
Essential arterial hypertension and stone disease
1999
Uncomplicated Urinary Tract Infection
2012 Standout
Epidemiology of stone disease across the world
2017 Standout
Comparison of Two Diets for the Prevention of Recurrent Stones in Idiopathic Hypercalciuria
2002 Standout
Serenoa repensfor benign prostatic hyperplasia
2009
Current aspects of epidemiology and nutrition in urinary stone disease
1997
EAU Guidelines on Diagnosis and Conservative Management of Urolithiasis
2015 Standout
Second cancer risk following testicular cancer: a follow-up study of 1,909 patients.
1993
Antipyrine as a model drug to study hepatic drug-metabolizing capacity
1988
Interactions Between Herbal Medicines and Prescribed Drugs
2001 Standout
Absence of Oxalobacter formigenes in cystic fibrosis patients: a risk factor for hyperoxaluria
1998
Prevalence of urolithiasis in the autonomous city of Buenos Aires, Argentina
2006
The Composition of Four‐hour Urine Samples from Patients with Calcium Oxalate Stone Disease
1987
Absence of Oxalobacter Formigenes in Cystic Fibrosis Patients: A Risk Factor for Hyperoxaluria
1999
Gut Microbiota in Health and Disease
2010 Standout
Results of 5035 Stone Analyses: A Contribution to Epidemiology of Urinary Stone Disease
1990
Medical Management of Kidney Stones: AUA Guideline
2014 Standout
Does the Use of Chitosan Contribute to Oxalate Kidney Stone Formation?
2014 Standout
The influence of dietary factors on the risk of urinary stone formation.
1993
Drinking Water Nitrate and Human Health: An Updated Review
2018 Standout
Special Issue: KDIGO Clinical Practice Guideline for the Care of Kidney Transplant Recipients
2009 Standout
International Clinical Practice Guidelines for the Treatment of Acute Uncomplicated Cystitis and Pyelonephritis in Women: A 2010 Update by the Infectious Diseases Society of America and the European Society for Microbiology and Infectious Diseases
2011 Standout
How important are comprehensive literature searches and the assessment of trial quality in systematic reviews? Empirical study
2003 Standout
Diagnosis, Prevention, and Treatment of Catheter-Associated Urinary Tract Infection in Adults: 2009 International Clinical Practice Guidelines from the Infectious Diseases Society of America
2010 Standout
EFFECTS OF A SAW PALMETTO HERBAL BLEND IN MEN WITH SYMPTOMATIC BENIGN PROSTATIC HYPERPLASIA
2000
Dietary Intake and Habits Of Japanese Renal Stone Patients
1990
Adsorption of Thallium(I) Ions on Titania Particle Surfaces in Aqueous Media
2003
Time trends in reported prevalence of kidney stones in the United States: 1976–199411.See Editorial by Goldfarb, p. 1951.
2003 Standout
Conservative management for postprostatectomy urinary incontinence
2015
Dependence of urine composition on the age and sex of healthy subjects
1986
Oxalate and Urinary Stones
2000
Efficacy, safety, quality control, marketing and regulatory guidelines for herbal medicines (phytotherapeutic agents)
2000 Standout
Kidney stones: a global picture of prevalence, incidence, and associated risk factors.
2010 Standout

Works of D. Bach being referenced

Enzyme Activities in Tissue of HumanBenign Prostatic Hyperplasia afterThree Months' Treatment with theSabalserrulata Extract IDS 89(Strogen®) or Placebo
1997
Influence of nitrate levels in drinking water on urological malignancies: a community‐based cohort study
2005
Urinary incontinence and voiding dysfunction after radical retropubic prostatectomy (prospective urodynamic study)
2005
Urinary Calcium Oxalate Saturation in Healthy Infants and Children
1997
The determination of thallium in urine
1963
[Citric acid excretion in stone-formers and healthy controls on normal and standard diet (author's transl)].
1980
Rufloxacin Once Daily Versus Ciprofloxacin Twice Daily in the Treatment of Patients with Acute Uncomplicated Pyelonephritis
1995
Therapie und Rezidivprophylaxe der Harnsteine
2008
Urinary Calcium Oxalate Saturation in Healthy Infants and Children
1997
Gas-chromatographische Bestimmung von Oxalsäure im Harn unter normaler und oxalatreicher Ernährung
1980
Epidemiology, pathogenesis and diagnosis of calcium oxalate urolithiasis
1982
The effect of verapamil on antipyrine pharmacokinetics and metabolism in man.
1986
Bilateral Testicular Tumor
1983
Circadian rhythm of lithogenic substances in the urine
1982
Incidence, prevalence and mortality of urolithiasis in the German Federal Republic
1982
Rankless by CCL
2026